← Back to Search

Screening Tool for Substance Abuse (TAPS-ESP Trial)

N/A
Recruiting
Led By Katherine Sanchez, PhD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

TAPS-ESP Trial Summary

This trial looks at a new screening and assessment tool for substance use in primary care settings.

Who is the study for?
This trial is for Spanish-speaking adults who are current patients at the clinic and can read Spanish. It's designed for those seeking screening and treatment for substance use, including tobacco, alcohol, prescription drugs, or other illicit substances.Check my eligibility
What is being tested?
The study aims to validate the TAPS-ESP as a tool in primary care settings for identifying and assessing substance use issues. Participants will self-administer this screening tool on an iPad.See study design
What are the potential side effects?
Since this trial involves only a screening process using an electronic platform (TAPS-ESP), there are no direct medical side effects associated with participating in this study.

TAPS-ESP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ethanol
Secondary outcome measures
Alcohol Use Disorders Identification Test (AUDIT) for concurrent and convergent validity of the TAPS
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) for concurrent and convergent validity of the TAPS Tool
CAGE (Cut Down, Annoyed, Guilty, Eye-Opener) for concurrent and convergent validity of the TAPS
+2 more

TAPS-ESP Trial Design

2Treatment groups
Active Control
Group I: Self-Administration followed by Interviewer-AdministeredActive Control1 Intervention
Screening and validation of assessment tool translated into Spanish
Group II: Interviewer-Administered followed by Self-AdministrationActive Control1 Intervention
Screening and validation of assessment tool translated into Spanish

Find a Location

Who is running the clinical trial?

COG AnalyticsOTHER
3 Previous Clinical Trials
230 Total Patients Enrolled
Baylor Research InstituteLead Sponsor
200 Previous Clinical Trials
202,226 Total Patients Enrolled
Katherine Sanchez, PhDPrincipal InvestigatorBaylor Scott and White Research Institute
3 Previous Clinical Trials
600 Total Patients Enrolled

Media Library

TAPS-ESP Clinical Trial Eligibility Overview. Trial Name: NCT05476588 — N/A
Substance Abuse Research Study Groups: Self-Administration followed by Interviewer-Administered, Interviewer-Administered followed by Self-Administration
Substance Abuse Clinical Trial 2023: TAPS-ESP Highlights & Side Effects. Trial Name: NCT05476588 — N/A
TAPS-ESP 2023 Treatment Timeline for Medical Study. Trial Name: NCT05476588 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial presently welcoming participants?

"According to the clinicaltrials.gov registry, this research study is still seeking participants and was most recently updated on July 25th 2021. The investigation initially opened for recruitment on 15th of July 2020."

Answered by AI

How many people are participating in this experiment at its peak?

"Affirmative. The data published on clinicaltrials.gov suggests that this experiment is actively searching for participants, having been posted on July 15th 2022 and updated just 10 days later. A total of 1000 patients need to be enrolled from one medical centre."

Answered by AI

Who else is applying?

What site did they apply to?
Baylor Scott and White Community Care
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform
2022. "Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05476588.
All > Substance Abuse
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top